Alaris Medical Systems Inc – ‘15-15D’ on 6/30/03

On: Monday, 6/30/03, at 5:10pm ET · Effective: 6/30/03 · Accession #: 1029069-3-6 · File #: 333-18687

  As Of                Filer                Filing    For·On·As Docs:Size

 6/30/03  Alaris Medical Systems Inc        15-15D      6/30/03    1:11K

Notice of Suspension of Duty to File Reports — Form 15
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 15-15D      Notice of Suspension of Duty to File Reports        HTML     13K

This is an HTML Document rendered as filed. [ Alternative Formats ]

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 15

CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(G) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTION 13 AND 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934.

Commission File No. 333-18687

ALARIS MEDICAL SYSTEMS, INC. (formerly known as ALARIS MEDICAL, INC., and filing on behalf of ALARIS MEDICAL SYSTEMS, INC.)

(Exact name of registrant as specified in its charter)

10221 Wateridge Circle San Diego, California 92121-1579 (858) 458-7000

(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)

11-5/8% Senior Secured Notes due 2006 and 9-3/4% Senior Subordinated Notes due 2006

(Title of each class of securities covered by this Form)

	None

(Titles of all other classes of securities for which a duty
to file reports under section 13(a) or 15(d) remains)

Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:


Rule 12g-4(a)(1)(i)	\|_\|	Rule 12h-3(b)(1)(i)	\|X\|
Rule 12g-4(a)(1)(ii)	\|_\|	Rule 12h-3(b)(1)(ii)	\|_\|
Rule 12g-4(a)(2)(i)	\|_\|	Rule 12h-3(b)(2)(i)	\|_\|
Rule 12g-4(a)(2)(ii)	\|_\|	Rule 12h-3(b)(2)(ii)	\|_\|
		Rule 15d-6	\|X\|

Approximate number of holders of record as of the certification or notice date: None, as all Notes were retired.

Pursuant to the requirements of the Securities Exchange Act of 1934, ALARIS Medical Systems, Inc., as the successor by way of merger with the registrant, has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.

		ALARIS MEDICAL SYSTEMS, INC.
Date: June 30, 2003		/s/*DAVID L. SCHLOTTERBECK* David L. Schlotterbeck President and Chief Executive Officer

Dates Referenced Herein

This ‘15-15D’ Filing	Date	Other Filings

Filed on / Effective on:	6/30/03	None on these Dates
		List all Filings

↑Top

Filing Submission 0001029069-03-000006 – Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)